APO Research
Talk to an analyst

APO RESEARCH · REPORT

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Growth and Trends Forecast to 2032

4 July 2026109 pages

Choose your research edition.

Industry ResearchInduced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Growth and Trends Forecast to 2032109 pages · $3,450 USDMarket StructureGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit include INNOBIO, Cellapy, Merck, Thermo Fisher, REPROCELL, Qurgen, Bio-Techne, Applied StemCell and ALSTEM, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Company

INNOBIO

Cellapy

Merck

Thermo Fisher

REPROCELL

Qurgen

Bio-Techne

Applied StemCell

ALSTEM

Abcam

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Type

Feeder Based Reprogramming

Feeder-free Based Reprogramming

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Application

Life Science and Medical Research Colleges (Institutes)

Biotechnology Company

Biomedical Pharmaceutical Factory

Hospital Clinical Research Institution

Others

Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Feeder Based Reprogramming Table 2. Major Company of Feeder-free Based Reprogramming Table 3. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 5. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type (2021-2026) Table 6. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 7. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type (2021-2026) Table 8. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Price by Type (2021-2026) & (USD/unit) Table 9. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2027-2032) & (k units) Table 10. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type (2027-2032) Table 11. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2027-2032) & (US$ Million) Table 12. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type (2027-2032) Table 13. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Price by Type (2027-2032) & (USD/unit) Table 14. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 15. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 17. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 21. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Type (2021-2026) & (US$ Million) Table 24. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Trends Table 25. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Drivers Table 26. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Opportunities and Challenges Table 27. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Restraints Table 28. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue Market Share by Company (2021-2026) Table 30. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Company (2021-2026) & (k units) Table 31. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Company (2021-2026) Table 32. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Major Company Production Sites and Headquarters Table 35. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Company, Product Type & Application Table 36. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2021-2026) & (k units) Table 41. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Region (2021-2026) Table 42. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2021-2026) & (US$ Million) Table 43. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Region (2021-2026) Table 44. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2027-2032) & (k units) Table 46. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Region (2027-2032) Table 47. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Region (2027-2032) & (US$ Million) Table 48. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Region (2027-2032) Table 49. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 52. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application (2021-2026) Table 53. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 54. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application (2021-2026) Table 55. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Price by Application (2021-2026) & (USD/unit) Table 56. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2027-2032) & (k units) Table 57. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application (2027-2032) Table 58. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2027-2032) & (US$ Million) Table 59. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application (2027-2032) Table 60. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Price by Application (2027-2032) & (USD/unit) Table 61. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 62. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 64. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 68. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Application (2021-2026) & (US$ Million) Table 71. INNOBIO Company Information Table 72. INNOBIO Business Overview Table 73. INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 75. INNOBIO Recent Development Table 76. Cellapy Company Information Table 77. Cellapy Business Overview Table 78. Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 80. Cellapy Recent Development Table 81. Merck Company Information Table 82. Merck Business Overview Table 83. Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 85. Merck Recent Development Table 86. Thermo Fisher Company Information Table 87. Thermo Fisher Business Overview Table 88. Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 90. Thermo Fisher Recent Development Table 91. REPROCELL Company Information Table 92. REPROCELL Business Overview Table 93. REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 95. REPROCELL Recent Development Table 96. Qurgen Company Information Table 97. Qurgen Business Overview Table 98. Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 100. Qurgen Recent Development Table 101. Bio-Techne Company Information Table 102. Bio-Techne Business Overview Table 103. Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 105. Bio-Techne Recent Development Table 106. Applied StemCell Company Information Table 107. Applied StemCell Business Overview Table 108. Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 110. Applied StemCell Recent Development Table 111. ALSTEM Company Information Table 112. ALSTEM Business Overview Table 113. ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 115. ALSTEM Recent Development Table 116. Abcam Company Information Table 117. Abcam Business Overview Table 118. Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio Table 120. Abcam Recent Development Table 121. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 122. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 123. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2026) Table 124. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032) & (k units) Table 125. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share Forecast by Country (2027-2032) Table 126. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country (2021-2026) Table 129. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share Forecast by Country (2027-2032) Table 131. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 132. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 133. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2026) Table 134. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032) & (k units) Table 135. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country (2021-2026) Table 139. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 143. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032) & (k units) Table 145. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country (2021-2026) Table 149. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share Forecast by Country (2027-2032) Table 151. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 153. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2026) Table 154. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032) & (k units) Table 155. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country (2021-2026) Table 159. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026) & (k units) Table 163. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032) & (k units) Table 165. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country (2021-2026) Table 169. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Distributors List Table 174. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Image Figure 2. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (2021-2032) & (k units) Figure 5. Feeder Based Reprogramming Image Figure 6. Global Feeder Based Reprogramming Sales YoY Growth (2021-2032) & (k units) Figure 7. Feeder-free Based Reprogramming Image Figure 8. Global Feeder-free Based Reprogramming Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Type 2025 VS 2032 Figure 11. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type in 2025 Figure 12. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type in 2025 Figure 13. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type in 2025 Figure 14. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type in 2025 Figure 17. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Life Science and Medical Research Colleges (Institutes) Image Figure 24. Global Life Science and Medical Research Colleges (Institutes) Sales YoY Growth (2021-2032) & (k units) Figure 25. Biotechnology Company Image Figure 26. Global Biotechnology Company Sales YoY Growth (2021-2032) & (k units) Figure 27. Biomedical Pharmaceutical Factory Image Figure 28. Global Biomedical Pharmaceutical Factory Sales YoY Growth (2021-2032) & (k units) Figure 29. Hospital Clinical Research Institution Image Figure 30. Global Hospital Clinical Research Institution Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Application 2025 VS 2032 Figure 35. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application in 2025 Figure 36. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application in 2025 Figure 37. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application in 2025 Figure 38. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application in 2025 Figure 41. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Market Share in Value by Application in 2025 Figure 45. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Feeder Based Reprogramming
  • Feeder-free Based Reprogramming
Applications
  • Life Science and Medical Research Colleges (Institutes)
  • Biotechnology Company
  • Biomedical Pharmaceutical Factory
  • Hospital Clinical Research Institution
  • Others
Companies covered
  • INNOBIO
  • Cellapy
  • Merck
  • Thermo Fisher
  • REPROCELL
  • Qurgen
  • Bio-Techne
  • Applied StemCell
  • ALSTEM
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Type
  6. 1.3.1 Feeder Based Reprogramming
  7. 1.3.2 Feeder-free Based Reprogramming
  8. 1.4 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Type
  9. 1.4.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Trends
  2. 2.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Drivers
  3. 2.3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Opportunities and Challenges
  4. 2.4 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (2021-2026)
  3. 3.3 Global Top Players by Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Price (2021-2026)
  4. 3.4 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Major Company Production Sites & Headquarters
  6. 3.6 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Company, Product Type & Application
  7. 3.7 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Tier 1, Tier 2, and Tier 3
4 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Regional Status and Outlook
  1. 4.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Historic Market Size by Region
  3. 4.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Forecasted Market Size by Region
  7. 4.3.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit by Application
  1. 5.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market by Application
  2. 5.1.1 Life Science and Medical Research Colleges (Institutes)
  3. 5.1.2 Biotechnology Company
  4. 5.1.3 Biomedical Pharmaceutical Factory
  5. 5.1.4 Hospital Clinical Research Institution
  6. 5.1.5 Others
  7. 5.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Application
  8. 5.2.1 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 INNOBIO
  2. 6.1.1 INNOBIO Company Information
  3. 6.1.2 INNOBIO Business Overview
  4. 6.1.3 INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 INNOBIO Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  6. 6.1.5 INNOBIO Recent Developments
  7. 6.2 Cellapy
  8. 6.2.1 Cellapy Company Information
  9. 6.2.2 Cellapy Business Overview
  10. 6.2.3 Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Cellapy Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  12. 6.2.5 Cellapy Recent Developments
  13. 6.3 Merck
  14. 6.3.1 Merck Company Information
  15. 6.3.2 Merck Business Overview
  16. 6.3.3 Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  18. 6.3.5 Merck Recent Developments
  19. 6.4 Thermo Fisher
  20. 6.4.1 Thermo Fisher Company Information
  21. 6.4.2 Thermo Fisher Business Overview
  22. 6.4.3 Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Thermo Fisher Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  24. 6.4.5 Thermo Fisher Recent Developments
  25. 6.5 REPROCELL
  26. 6.5.1 REPROCELL Company Information
  27. 6.5.2 REPROCELL Business Overview
  28. 6.5.3 REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 REPROCELL Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  30. 6.5.5 REPROCELL Recent Developments
  31. 6.6 Qurgen
  32. 6.6.1 Qurgen Company Information
  33. 6.6.2 Qurgen Business Overview
  34. 6.6.3 Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Qurgen Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  36. 6.6.5 Qurgen Recent Developments
  37. 6.7 Bio-Techne
  38. 6.7.1 Bio-Techne Company Information
  39. 6.7.2 Bio-Techne Business Overview
  40. 6.7.3 Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Bio-Techne Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  42. 6.7.5 Bio-Techne Recent Developments
  43. 6.8 Applied StemCell
  44. 6.8.1 Applied StemCell Company Information
  45. 6.8.2 Applied StemCell Business Overview
  46. 6.8.3 Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Applied StemCell Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  48. 6.8.5 Applied StemCell Recent Developments
  49. 6.9 ALSTEM
  50. 6.9.1 ALSTEM Company Information
  51. 6.9.2 ALSTEM Business Overview
  52. 6.9.3 ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 ALSTEM Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  54. 6.9.5 ALSTEM Recent Developments
  55. 6.10 Abcam
  56. 6.10.1 Abcam Company Information
  57. 6.10.2 Abcam Business Overview
  58. 6.10.3 Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Abcam Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Product Portfolio
  60. 6.10.5 Abcam Recent Developments
7 North America by Country
  1. 7.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country
  2. 7.1.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026)
  4. 7.1.3 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country
  6. 7.2.1 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country
  2. 8.1.1 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country
  6. 8.2.1 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country
  2. 9.1.1 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country
  6. 9.2.1 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country
  2. 10.1.1 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026)
  4. 10.1.3 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country
  6. 10.2.1 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country
  2. 11.1.1 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country
  6. 11.2.1 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Value Chain Analysis
  2. 12.1.1 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Production Mode & Process
  7. 12.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Distributors
  10. 12.2.3 Induced Pluripotent Stem Cell (iPSC) Reprogramming Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst